Clinical electrophysiology, efficacy and safety of chronic oral cibenzoline therapy in refractory ventricular tachycardia

The American Journal of Cardiology
S T Rothbart, S Saksena


The electrocardiographic (ECG) and electrophysiologic (EP) effects, clinical efficacy and safety of oral cibenzoline therapy were evaluated using a twice-daily dosing regimen in patients with refractory ventricular tachycardia (VT). Twenty patients underwent EP studies in the control (drug-free) state and after cibenzoline therapy using an incremental dose-titration protocol. Oral cibenzoline (2.4 to 5.8 mg/kg/day) was administered in doses of 130, 160 or 190 mg at 12-hour intervals. ECG and EP variables, 24-hour ambulatory ECG monitoring and programmed electrical stimulation studies were obtained in the control state and after 11 +/- 4 days of cibenzoline therapy. Cibenzoline therapy prolonged the mean PR interval (from 179 +/- 29 to 201 +/- 36 ms, p less than 0.001), the mean QRS duration (from 107 +/- 21 to 130 +/- 25 ms, p less than 0.001), and the mean QTc interval (from 422 +/- 25 to 460 +/- 42 ms, p less than 0.001). It increased the mean HV interval (from 50 +/- 17 to 65 +/- 20 ms, p less than 0.01) and mean right ventricular effective refractory period (from 245 +/- 24 to 266 +/- 27 ms, p less than 0.01). After cibenzoline therapy, 5 patients (25%) had suppression of inducible sustained VT during programmed electrical ...Continue Reading


Jun 1, 1983·International Journal of Cardiology·S SaksenaG Cappello
Aug 1, 1984·Journal of the American College of Cardiology·J B KostisN Cosgrove
Jul 1, 1983·British Journal of Pharmacology·J S Millar, E M Vaughan Williams
Mar 1, 1984·Journal of the American College of Cardiology·K F BrowneJ J Heger
Jun 16, 1983·The New England Journal of Medicine·C D SwerdlowJ W Mason
Jan 1, 1983·European Journal of Clinical Pharmacology·M CanalA Dufour

❮ Previous
Next ❯


Nov 1, 1992·Journal of Clinical Pharmacology·E M Vaughan Williams
Feb 1, 1995·Cardiovascular Drugs and Therapy·P BruS Lévy
Dec 5, 1989·The American Journal of Cardiology·P Jaillon, M Drici
Apr 1, 1991·International Journal of Cardiology·V KühlkampL Seipel
Sep 1, 1987·Journal of Clinical Pharmacology·P ZempolJ C Somberg
Aug 29, 2017·Therapeutic Advances in Drug Safety·Jonathan J H Bray, Jules C Hancox

❮ Previous
Next ❯

Related Concepts

Related Feeds


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.